Lavaca Capital’s Idexx Laboratories IDXX Stock Holding History

Lavaca Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$303K	Hold	540	–	–	0.05%	87
2025 Q4	$365K	Hold	540	–	–	0.06%	73
2025 Q3	$345K	Hold	540	–	–	0.06%	75
2025 Q2	$290K	Hold	540	–	–	0.11%	86
2025 Q1	$227K	Hold	540	–	–	0.09%	97
2024 Q4	$223K	Hold	540	–	–	0.09%	111
2024 Q3	$273K	Hold	540	–	–	0.12%	94
2024 Q2	$263K	Hold	540	–	–	0.14%	74
2024 Q1	$292K	Hold	540	–	–	0.17%	66
2023 Q4	$300K	Hold	540	–	–	0.17%	75
2023 Q3	$236K	Hold	540	–	–	0.08%	133
2023 Q2	$271K	Hold	540	–	–	0.08%	138
2023 Q1	$270K	Hold	540	–	–	0.06%	164
2022 Q4	$220K	Buy	+540	New	+$210K	0.07%	164
2022 Q2	–	Sell	-540	Closed	-$295K	–	172
2022 Q1	$295K	Hold	540	–	–	0.03%	166
2021 Q4	$356K	Hold	540	–	–	0.05%	129
2021 Q3	$336K	Sell	540 -109	-17%	-$73.2K	0.03%	125
2021 Q2	$410K	Sell	649 -192	-23%	-$106K	0.04%	116
2021 Q1	$412K	Buy	841 +63	+8%	+$31.6K	0.04%	98
2020 Q4	$389K	Buy	778 +238	+44%	+$106K	0.05%	80
2020 Q3	$212K	Buy	+540	New	+$200K	0.03%	103
2019 Q2	–	Sell	-540	Closed	-$121K	–	205
2019 Q1	$121K	Sell	540 -696	-56%	-$144K	0.1%	99
2018 Q4	$230K	Buy	+1,236	New	+$253K	0.23%	55

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Lavaca Capital's IDXX Position: Q1 2026 in Review

Lavaca Capital held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 540 shares worth $303K. The position accounts for 0.05% of the portfolio, ranked #87.

Lavaca Capital first reported a position in IDXX in Q4 2018 and has held it in 23 quarters since. The position peaked at $412K in Q1 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Lavaca Capital held 540 shares of Idexx Laboratories worth $303K as of Q1 2026.
Lavaca Capital left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up 0.05% of Lavaca Capital's portfolio in Q1 2026, its #87 holding.
Lavaca Capital first reported a position in Idexx Laboratories in Q4 2018 and has held it in 23 quarters since.
Lavaca Capital's Idexx Laboratories position peaked at $412K in Q1 2021.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.